Sudeep Pharma IPO Allotment Live Updates: Here’s How To Check Status On BSE, NSE And MUFG Intime

Sudeep Pharma ipo gmp Live: Sudeep Pharma Limited ipo closed for subscription on Tuesday, November 25. The issue is structured as a book-building IPO worth Rs 895 crores, combining a fresh issue of 0.16 crore shares (Rs 95 crores) and an offer for sale of 1.35 crore shares (Rs 800 crores).

The price band for the IPO is fixed between Rs 563 and Rs 593 per share, with the final issue price at Rs 593.

Key IPO Dates and Details

Investors can subscribe to the Sudeep Pharma IPO starting November 21, 2025, with the subscription window closing on November 25, 2025. The allotment is expected on November 26, 2025, followed by refunds on November 27, 2025. The tentative listing on BSE and NSE is set for November 28, 2025.

Lot Sizes And Investments

Retail investors can apply for a minimum of 25 shares (Rs 14,825 at the upper price) and up to 325 shares.

S-HNIs and B-HNIs can apply for 350–1,700 shares, amounting to Rs 2.07 lakh to Rs 10.08 lakh.

Anchor investors will contribute Rs 268.50 crores, with partial lock-in ending on December 26, 2025, and full lock-in by February 24, 2026.

Allocation And Promoter Holdings

The IPO allocation is split across investor categories:

QIB: 50 per cent of shares (75.46 lakh)

NII (HNI): 15 per cent (22.63 lakh)

Retail investors: 35 per cent (52.82 lakh)

Anchor investors: 30 per cent (45.27 lakh)

Promoters, including Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Limited, and Bhayani Family Trust, will reduce their holding from 89.37 per cent to 76.15 per cent post-IPO.

About Sudeep Pharma

Founded in 1989, Sudeep Pharma specialises in pharmaceutical excipients, minerals like calcium, iron, magnesium, zinc, potassium, and sodium, and speciality nutrition ingredients. With strong R&D capabilities, the company operates six plants with a total capacity of 50,000 MT. Its products serve the pharma, food, and nutrition sectors globally, making this IPO a significant investment opportunity.